Dashboard
Manage Tickers

ERNA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ernexa-therapeutics-to-present-preclinical-data-on-gene-modified-ips-derived-mscs-reprogramming-immune-microenvironment-in-high-grade-serous-ovarian-cancer-at-aacr-conference-on-september-20
Ernexa Therapeutics To Present Preclinical...
09/17/2025 12:36:50

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/15/2025 21:06:07

correction-ernexa-therapeutics-cuts-operating-loss-decreased-by-55m-or-51-from-107m-during-the-6-months-ending-on-june-30-2024-to-52m-during-the-6-months-ending-on-june-30-2025
CORRECTION: Ernexa Therapeutics Cuts Opera...
09/10/2025 12:49:30

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/09/2025 21:06:08

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/29/2025 21:06:12

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
07/25/2025 21:06:49

ernexa-therapeutics-regains-nasdaq-compliance
Ernexa Therapeutics Regains Nasdaq Compliance
07/09/2025 12:35:19

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 17:06:36

ernexa-therapeutics-receives-6m-in-second-closing-under-securities-purchase-agreement-with-certain-accredited-investors
Ernexa Therapeutics Receives ~$6M In Secon...
06/24/2025 12:31:56

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
06/12/2025 12:55:07

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/11/2025 23:50:05

ernexa-therapeutics-announces-1-for-15-reverse-stock-split-effective-june-12-2025
Ernexa Therapeutics Announces 1-For-15 Rev...
06/10/2025 13:31:21

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 17:06:51

reported-june-2-2025-ernexa-therapeutics-amends-certificate-of-incorporation-to-increase-authorized-common-stock-from-100m-to-150m-shares
Reported June 2, 2025: Ernexa Therapeutics...
06/03/2025 14:50:51

Effective June 2, 2025, Ernexa Therapeutics Inc. (the "Company"), filed a certificate of amendment to the Company's...

ernexa-therapeutics-establishes-texas-subsidiary-to-support-ongoing-development-of-erna-101-and-future-clinical-operations
Ernexa Therapeutics Establishes Texas Subs...
05/14/2025 12:35:15

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
04/17/2025 21:05:38

rnexa-therapeutics-files-prospectus-for-resale-of-104m-shares-of-common-stock
Rnexa Therapeutics Files Prospectus For Re...
04/16/2025 20:34:57

-SEC Filing

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/03/2025 21:05:48

eterna-therapeutics-changes-name-to-ernexa-therapeutics
Eterna Therapeutics Changes Name to Ernexa...
03/25/2025 12:31:20

Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, today announced th...

eterna-therapeutics-announces-inaugural-scientific-advisory-board-meeting-discussed-erna-101-preclinical-advances-in-ovarian-cancer-focused-on-immune-activation-tumor-microenvironment-combination-therapies-and-erna-102-for-autoimmune-diseases
Eterna Therapeutics Announces Inaugural Sc...
02/26/2025 13:45:40

Some highlights from the meeting include:The board discussed the positive preclinical data for ERNA-101 in ovarian cancer, incl...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION